Not recruiting
Acute myeloid leukaemia
Not recruitingStudy on the Safety and Effectiveness of Mebendazole and Low-Dose Cytarabine for Elderly Patients with Relapsed or Refractory Acute Myeloid Leukemia
Registered drugNo placebo
Study on the Safety and Effectiveness of Mebendazole and Low-Dose Cytarabine for Elderly Patients with Relapsed or Refractory Acute Myeloid Leukemia
Registered drugNo placebo
- Disease:Acute myeloid leukaemia
- Substances:CytarabineMebendazole
Countries:
Germany
Germany- Participants:65+ years
- Substances:Cytarabine
